# Mapping Small Extracellular Vesicle Secretion Potential in Healthy Human Gingiva Using Spatial Transcriptomics

**Authors:** Blanka Maria Borowiec, Małgorzata Blatkiewicz, Marta Dyszkiewicz-Konwińska, Dorota Bukowska, Bartosz Kempisty, Marcin Ruciński, Michał Nowicki, Joanna Budna-Tukan

PMC · DOI: 10.3390/cimb47040256 · 2025-04-07

## TL;DR

This study uses spatial transcriptomics to explore how small extracellular vesicles are produced in healthy human gum tissue, revealing new insights into tissue regeneration.

## Contribution

The first meta-analysis of gingival transcriptomic data focused on small extracellular vesicle biogenesis.

## Key findings

- Gene clusters related to extracellular vesicle biogenesis were identified in the sulcular epithelium of the gingiva.
- MUC1, SDCBP2, and VPS37B showed the highest expression in the superficial layer of the sulcular epithelium.
- Known sEV markers like CD9 and CD63 were expressed in the tissue but not exclusively in the sulcular epithelium.

## Abstract

Regenerative processes occur at various levels in all organisms, yet their complexity continues to raise new questions about their mechanisms. It has been demonstrated that small extracellular vesicles (sEVs), secreted by all cells and influencing their function, play a significant role in regeneration. In the context of regenerative processes, oral mucosal tissues consistently receive interest, as they are among the most rapidly healing tissues in the human body. In this study, we utilized spatial transcriptomics to map gene expression to specific spatial locations within the gingiva tissue section, using publicly available transcriptomic data. This analysis revealed new insights into this tissue and the biogenesis of sEVs within it. The identified clusters encompassed two main regions—the epithelium and lamina propria—as well as minor niches within them. Using Gene Ontology (GO) analysis, we identified two clusters most enriched in extracellular vesicle-related GO processes. These included the superficial and deeper layers of the sulcular epithelium, one of the most peripheral regions of the gingiva. Of the 43 genes identified in the literature as having a potential or documented role in sEVs biogenesis, 12 were selected for further analysis. MUC1, SDCBP2, and VPS37B showed clear specificity and the highest expression in the superficial layer of the sulcular epithelium. CHMP4C also exhibited high expression in this layer, though its levels were comparable to the outer layer of the oral epithelium. Other well-established sEVs marker genes, such as ANXA2, CD9, CD63, CD81, FLOT1, RAB22A, RAB27B, and RAB5A, were also expressed in the examined tissue; however, their expression was not specifically exclusive to the sulcular epithelium. Our study is the first to perform a meta-analysis of available gingival transcriptomic data in the specific context of sEVs biogenesis. The presented data and conclusions provide new insights into the role of different structures within healthy human gingiva and shed new light on both known and potential markers of sEVs biogenesis. These findings may contribute to the development of regeneration-targeted research, especially on oral tissues.

## Linked entities

- **Genes:** MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582], SDCBP2 (syndecan binding protein 2) [NCBI Gene 27111], VPS37B (VPS37B subunit of ESCRT-I) [NCBI Gene 79720], CHMP4C (charged multivesicular body protein 4C) [NCBI Gene 92421], ANXA2 (annexin A2) [NCBI Gene 302], CD9 (CD9 molecule) [NCBI Gene 928], CD63 (CD63 molecule) [NCBI Gene 967], CD81 (CD81 molecule) [NCBI Gene 975], FLOT1 (flotillin 1) [NCBI Gene 10211], RAB22A (RAB22A, member RAS oncogene family) [NCBI Gene 57403], RAB27B (RAB27B, member RAS oncogene family) [NCBI Gene 5874], RAB5A (RAB5A, member RAS oncogene family) [NCBI Gene 5868]

## Full-text entities

- **Genes:** VPS37B (VPS37B subunit of ESCRT-I) [NCBI Gene 79720], CD63 (CD63 molecule) [NCBI Gene 967] {aka AD1, HOP-26, ME491, MLA1, OMA81H, Pltgp40}, ANXA2 (annexin A2) [NCBI Gene 302] {aka ANX2, ANX2L4, CAL1H, HEL-S-270, LIP2, LPC2}, SDCBP2 (syndecan binding protein 2) [NCBI Gene 27111] {aka SITAC, SITAC18, ST-2, ST2}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, FLOT1 (flotillin 1) [NCBI Gene 10211], RAB22A (RAB22A, member RAS oncogene family) [NCBI Gene 57403], CD9 (CD9 molecule) [NCBI Gene 928] {aka BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29}, RAB5A (RAB5A, member RAS oncogene family) [NCBI Gene 5868] {aka RAB5}, RAB27B (RAB27B, member RAS oncogene family) [NCBI Gene 5874] {aka C25KG}, CD81 (CD81 molecule) [NCBI Gene 975] {aka CVID6, S5.7, TAPA1, TSPAN28}
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** CHMP4C — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_XM78)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12026306/full.md

---
Source: https://tomesphere.com/paper/PMC12026306